Parietal Epithelial Cells and Podocytes in Glomerular Diseases

Seminars in Nephrology

Volumn 32, Issue 4, 2012, Pages 357-367

  Smeets, Bart ^a,b   Moeller, Marcus J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glomerulus; Lineage tracing; Parietal epithelial cells; Podocyte

Indexed keywords

HERMES ANTIGEN; KIDNEY INJURY MOLECULE 1;

ARTICLE; BOWMAN CAPSULE; BOWMAN MEMBRANE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CELL REGENERATION; COLLAPSING GLOMERULOPATHY; EPITHELIUM CELL; FOCAL GLOMERULONEPHRITIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS EPITHELIUM; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FAILURE; MESANGIUM CELL; NONHUMAN; PARIETAL EPITHELIAL CELL; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

ANIMALS; EPITHELIAL CELLS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; PODOCYTES;

EID: 84865788188     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.06.007     Document Type: Article

References (114)

1. Crabtree C. Sex differences in the structure of Bowman's capsule in the mouse. Science 1940, 91:299.
2. Dressler G.R. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006, 22:509-529.
3. Horster M.F., Braun G.S., Huber S.M. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 1999, 79:1157-1191.
4. Saxen L., Sariola H. Early organogenesis of the kidney. Pediatr Nephrol 1987, 1:385-392.
5. Nagata M., Yamaguchi Y., Ito K. Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat Embryol (Berl) 1993, 187:275-279.
6. Reeves W., Caulfield J.P., Farquhar M.G. Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab Invest 1978, 39:90-100.
7. Abrahamson D.R. Structure and development of the glomerular capillary wall and basement membrane. Am J Physiol 1987, 253:F783-F794.
8. Skoberne A., Konieczny A., Schiffer M. Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol 2009, 296:F230-F241.
9. Kanemoto K., Takahashi S., Shu Y., Usui J., Tomari S., Yan K., et al. Variable expression of podocyte-related markers in the glomeruloid bodies in Wilms tumor. Pathol Int 2003, 53:596-601.
10. Nacher V., Carretero A., Navarro M., Armengol C., Llombart C., Blasi J., et al. Beta-catenin expression during vascular development and degeneration of avian mesonephros. J Anat 2005, 206:165-174.
11. Grouls S., Iglesias D.M., Wentzensen N., Moeller M.J., Bouchard M., Kemler R., et al. Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol 2012, 23:63-72.
12. Pinto D., Gregorieff A., Begthel H., Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003, 17:170913.
13. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001, 105:533-545.
14. Ueda H., Miyazaki Y., Matsusaka T., Utsunomiya Y., Kawamura T., Hosoya T., et al. Bmp in podocytes is essential for normal glomerular capillary formation. J Am Soc Nephrol 2008, 19:685-694.
15. Changsirikulchai S., Hudkins K.L., Goodpaster T.A., Volpone J., Topouzis S., Gilbertson D.G., et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 2002, 62:2043-2054.
16. Fujigaki Y., Sun D.F., Fujimoto T., Suzuki T., Goto T., Yonemura K., et al. Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents. Nephron 2002, 92:203-212.
17. Ophascharoensuk V., Pippin J.W., Gordon K.L., Shankland S.J., Couser W.G., Johnson R.J. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998, 54:416-425.
18. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., Bowen-Pope D.F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 1993, 43:286-294.
19. van Roeyen C.R., Eitner F., Boor P., Moeller M.J., Raffetseder U., Hanssen L., et al. Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney Int 2011, 80:1292-1305.
20. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20:333-343.
21. Vogelmann S.U., Nelson W.J., Myers B.D., Lemley K.V. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003, 285:F40-F48.
22. Yu D., Petermann A., Kunter U., Rong S., Shankland S.J., Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005, 16:1733-1741.
23. Hara M., Yamamoto T., Yanagihara T., Takada T., Itoh M., Adachi Y., et al. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 1995, 69:397-403.
24. Nagata M., Yamaguchi Y., Komatsu Y., Ito K. Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 1995, 70:68-71.
25. Pabst R., Sterzel R.B. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983, 24:626-631.
26. Floege J., Kriz W., Schulze M., Susani M., Kerjaschki D., Mooney A., et al. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 1995, 96:2809-2819.
27. Kriz W., Hahnel B., Rosener S., Elger M. Long-term treatment of rats with FGF2 results in focal segmental glomerulosclerosis. Kidney Int 1995, 48:1435-1450.
28. Becker J.U., Hoerning A., Schmid K.W., Hoyer P.F. Immigrating progenitor cells contribute to human podocyte turnover. Kidney Int 2007, 72:1468-1473.
29. Sugimoto H., Mundel T.M., Sund M., Xie L., Cosgrove D., Kalluri R. Bone marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A 2006, 103:7321-7326.
30. Prodromidi E.I., Poulsom R., Jeffery R., Roufosse C.A., Pollard P.J., Pusey C.D., et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006, 24:2448-2455.
31. Lin F., Moran A., Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005, 115:1756-1764.
32. Meyer-Schwesinger C., Lange C., Brocker V., Agustian P.A., Lehmann U., Raabe A., et al. Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol 2011, 178:494-499.
33. Gross O., Borza D.B., Anders H.J., Licht C., Weber M., Segerer S., et al. Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrol Dial Transplant 2009, 24:731-734.
34. Ronconi E., Sagrinati C., Angelotti M.L., Lazzeri E., Mazzinghi B., Ballerini L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009, 20:322-332.
35. Bariety J., Mandet C., Hill G.S., Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006, 17:2770-2780.
36. Nemeth Z., Kokeny G., Godo M., Mozes M., Rosivall L., Gross M.L., et al. Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies-the effect on podocytes. Nephrol Dial Transplant 2009, 24:3640-3651.
37. Macconi D., Sangalli F., Bonomelli M., Conti S., Condorelli L., Gagliardini E., et al. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol 2009, 174:797-807.
38. Benigni A., Morigi M., Rizzo P., Gagliardini E., Rota C., Abbate M., et al. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 2011, 179:628-638.
39. Couser W.G. Glomerulonephritis. Lancet 1999, 353:1509-1515.
40. Jennette J.C., Thomas D.B. Crescentic glomerulonephritis. Nephrol Dial Transplant 2001, 16(Suppl 6):80-82.
41. Le Hir M., Besse-Eschmann V. A novel mechanism of nephron loss in a murine model of crescentic glomerulonephritis. Kidney Int 2003, 63:591-599.
42. Singh S.K., Jeansson M., Quaggin S.E. New insights into the pathogenesis of cellular crescents. Curr Opin Nephrol Hypertens 2011, 20:258-262.
43. Le Hir M., Keller C., Eschmann V., Hahnel B., Hosser H., Kriz W. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2001, 12:2060-2071.
44. Boucher A., Droz D., Adafer E., Noel L.H. Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 1987, 56:526-533.
45. Thomson N.M., Moran J., Simpson I.J., Peters D.K. Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int 1976, 10:343-347.
46. Naish P., Penn G.B., Evans D.J., Peters D.K. The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 1972, 42:643-646.
47. Ding M., Cui S., Li C., Jothy S., Haase V., Steer B.M., et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006, 12:1081-1087.
48. Sayyed S.G., Hagele H., Kulkarni O.P., Endlich K., Segerer S., Eulberg D., et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009, 52:2445-2454.
49. Darisipudi M.N., Kulkarni O.P., Sayyed S.G., Ryu M., Migliorini A., Sagrinati C., et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol 2011, 179:116-124.
50. Takabatake Y., Sugiyama T., Kohara H., Matsusaka T., Kurihara H., Koni P.A., et al. The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009, 20:1714-1723.
51. Mazzinghi B., Ronconi E., Lazzeri E., Sagrinati C., Ballerini L., Angelotti M.L., et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008, 205:479-490.
52. Neusser M.A., Lindenmeyer M.T., Moll A.G., Segerer S., Edenhofer I., Sen K., et al. Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol 2010, 176:594-607.
53. Eitner F., Cui Y., Hudkins K.L., Stokes M.B., Segerer S., Mack M., et al. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol 2000, 11:856-867.
54. Brukamp K., Jim B., Moeller M.J., Haase V.H. Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. Am J Physiol Renal Physiol 2007, 293:F1397-F1407.
55. Steenhard B.M., Isom K., Stroganova L., St John P.L., Zelenchuk A., Freeburg P.B., et al. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria. Am J Pathol 2010, 177:84-96.
56. Bollee G., Flamant M., Schordan S., Fligny C., Rumpel E., Milon M., et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011, 17:1242-1250.
57. D'Agati V.D., Kaskel F.J., Falk R.J. Focal segmental glomerulosclerosis. N Engl J Med 2011, 365:2398-2411.
58. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 2003, 23:117-134.
59. Hildebrandt F. Genetic kidney diseases. Lancet 2010, 375:1287-1295.
60. McCarthy E.T., Sharma M., Savin V.J. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2011, 5:2115-2121.
61. Wei C., El Hindi S., Li J., Fornoni A., Goes N., Sageshima J., et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011, 17:952-960.
62. Clement L.C., Avila-Casado C., Mace C., Soria E., Bakker W.W., Kersten S., et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011, 17:117-122.
63. Kriz W., LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005, 67:404-419.
64. Smeets B., Kuppe C., Sicking E.M., Fuss A., Jirak P., van Kuppevelt T.H., et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011, 22:1262-1274.
65. Matsusaka T., Xin J., Niwa S., Kobayashi K., Akatsuka A., Hashizume H., et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 2005, 16:1013-1023.
66. Wharram B.L., Goyal M., Wiggins J.E., Sanden S.K., Hussain S., Filipiak W.E., et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005, 16:2941-2952.
67. Macary G., Rossert J., Bruneval P., Mandet C., Belair M.F., Houillier P., et al. Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury. Virchows Arch 2009, 456:325-337.
68. Sicking E.M., Fuss A., Uhlig S., Jirak P., Dijkman H., Wetzels J., et al. Subtotal ablation of parietal epithelial cells results in cellular activation and crescent formation. J Am Soc Nephrol 2012, 23:629-640.
69. Gaffney E.F. Prominent parietal epithelium: a common sign of renal glomerular injury. Hum Pathol 1982, 13:651-660.
70. Gaffney E.F., Panner B.J. Membranous glomerulonephritis: clinical significance of glomerular hypercellularity and parietal epithelial abnormalities. Nephron 1981, 29:209-215.
71. Smeets B., Uhlig S., Fuss A., Mooren F., Wetzels J.F., Floege J., et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 2009, 20:2604-2615.
72. Cichy J., Pure E. The liberation of CD44. J Cell Biol 2003, 161:839-843.
73. Ito T., Williams J.D., Al-Assaf S., Phillips G.O., Phillips A.O. Hyaluronan and proximal tubular cell migration. Kidney Int 2004, 65:823-833.
74. Yoo K.H., Thornhill B.A., Forbes M.S., Coleman C.M., Marcinko E.S., Liaw L., et al. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 2006, 70:1735-1741.
75. Rouschop K.M., Claessen N., Pals S.T., Weening J.J., Florquin S. CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis. J Am Soc Nephrol 2006, 17:746-753.
76. Zhao X., Zhang Y., Li L., Mann D., Imig J.D., Emmett N., et al. Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy. Am J Nephrol 2011, 34:268-280.
77. Ichimura T., Bonventre J.V., Bailly V., Wei H., Hession C.A., Cate R.L., et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998, 273:4135-4142.
78. Wiggins R.C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007, 71:1205-1214.
79. Van Damme B., Tardanico R., Vanrenterghem Y., Desmet V. Adhesions, focal sclerosis, protein crescents, and capsular lesions in membranous nephropathy. J Pathol 1990, 161:47-56.
80. Kretzler M., Koeppen-Hagemann I., Kriz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised desoxycorticosterone hypertensive rat. Virchows Arch 1994, 425:181-193.
81. Kriz W., Elger M., Nagata M., Kretzler M., Uiker S., Koeppen-Hageman I., et al. The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl 1994, 45:S64-S72.
82. Kriz W., Hartmann I., Hosser H., Hahnel B., Kranzlin B., Provoost A., et al. Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J Am Soc Nephrol 2001, 12:496-506.
83. Cai Y.I., Sich M., Beziau A., Kleppel M.M., Gubler M.C. Collagen distribution in focal and segmental glomerulosclerosis: an immunofluorescence and ultrastructural immunogold study. J Pathol 1996, 179:188-196.
84. Kihara I., Yaoita E., Kawasaki K., Yamamoto T., Hara M., Yanagihara T. Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy. Histopathology 1999, 34:537-547.
85. Nagata M., Horita S., Shu Y., Shibata S., Hattori M., Ito K., et al. Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 2000, 80:869-880.
86. Nagata M., Hattori M., Hamano Y., Ito K., Saitoh K., Watanabe T. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am J Kidney Dis 1998, 32:962-969.
87. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 2006, 70:338-344.
88. Suzuki T., Matsusaka T., Nakayama M., Asano T., Watanabe T., Ichikawa I., et al. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol 2009, 174:1675-1682.
89. Asano T., Niimura F., Pastan I., Fogo A.B., Ichikawa I., Matsusaka T. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005, 16:2257-2262.
90. Dijkman H., Smeets B., van der Laak J., Steenbergen E., Wetzels J. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int 2005, 68:1562-1572.
91. Smeets B., Angelotti M.L., Rizzo P., Dijkman H., Lazzeri E., Mooren F., et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009, 20:2593-2603.
92. Hill G.S., Karoui K.E., Karras A., Mandet C., Duong Van Huyen J.P., Nochy D., et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int 2011, 79:635-642.
93. Hodgin J.B., Borczuk A.C., Nasr S.H., Markowitz G.S., Nair V., Martini S., et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol 2010, 177:1674-1686.
94. Ohtaka A., Ootaka T., Sato H., Ito S. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?. Nephrol Dial Transplant 2002, 17(Suppl 9):11-15.
95. Yang Y., Gubler M.C., Beaufils H. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 2002, 91:416-423.
96. Bariety J., Nochy D., Mandet C., Jacquot C., Glotz D., Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998, 53:918-925.
97. Bariety J., Bruneval P., Hill G., Irinopoulou T., Mandet C., Meyrier A. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001, 12:261-274.
98. Barisoni L., Kriz W., Mundel P., D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999, 10:51-61.
99. Husain M., Gusella G.L., Klotman M.E., Gelman I.H., Ross M.D., Schwartz E.J., et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 2002, 13:1806-1815.
100. Conaldi P.G., Bottelli A., Baj A., Serra C., Fiore L., Federico G., et al. Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 2002, 161:53-61.
101. Moeller M.J. [Novel insights into the glomerular structure]. Dtsch Med Wochenschr 2010, 135:1232-1236.
102. Zhai Q.J., Ozcan A., Hamilton C., Shen S.S., Coffey D., Krishnan B., et al. PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol 2010, 18:323-332.
103. Diomedi-Camassei F., Rava L., Lerut E., Callea F., Van Damme B. Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney. Nephrol Dial Transplant 2005, 20:2714-2719.
104. Magil A.B. Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells. Am J Pathol 1985, 120:222-229.
105. Ostalska-Nowicka D., Nowicki M., Zachwieja J., Kasper M., Witt M. The significance of caveolin-1 expression in parietal epithelial cells of Bowman's capsule. Histopathology 2007, 51:611-621.
106. Sagrinati C., Netti G.S., Mazzinghi B., Lazzeri E., Liotta F., Frosali F., et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006, 17:2443-2456.
107. Seron D., Cameron J.S., Haskard D.O. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 1991, 6:917-922.
108. Patek C.E., Fleming S., Miles C.G., Bellamy C.O., Ladomery M., Spraggon L., et al. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Hum Mol Genet 2003, 12:2379-2394.
109. Shirato I., Asanuma K., Takeda Y., Hayashi K., Tomino Y. Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000, 11:2381-2386.
110. Bachmann S., Kriz W., Kuhn C., Franke W.W. Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins. Histochemistry 1983, 77:36594.
111. Kiuchi-Saishin Y., Gotoh S., Furuse M., Takasuga A., Tano Y., Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002, 13:875-886.
112. Aben J.A., Ijpelaar D.H., Baelde H., Worley P., Noble N., Bruijn J.A., et al. Glomerular expression of neuronal activity-regulated pentraxin precedes the development of anti-Thy-1-induced progressive glomerulosclerosis. Kidney Int 2006, 70:1279-1286.
113. Smeets B., Te Loeke N.A., Dijkman H.B., Steenbergen M.L., Lensen J.F., Begieneman M.P., et al. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 2004, 15:928-939.
114. Nelson P.J., Moissoglu K., Vargas J., Klotman P.E., Gelman I.H. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. J Cell Sci 1999, 112:361-370.